Trials / Sponsors / Halia Therapeutics, Inc.
Halia Therapeutics, Inc.
Industry · 6 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Study to Evaluate the Effect of HT-4253 for the Prevention of Alzheimer's Disease in APOE4 Carriers Alzheimers Disease | Phase 2 | 2026-04-03 |
| Withdrawn | A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants Diabetes Mellitus, Type 2, Obesity | Phase 2 | 2026-01-06 |
| Completed | Study to Evaluate HT-4253 in Healthy Subjects Normal Healthy Subjects | Phase 1 | 2024-09-17 |
| Completed | Evaluating Ability of HT-6184 to Reduce Inflammation and Pain After Third Molar Extraction Pain | Phase 2 | 2024-02-12 |
| Active Not Recruiting | A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia Myelodysplastic Syndrome, Anemia in Myelodysplastic Syndromes | Phase 2 | 2023-12-09 |
| Completed | Study to Evaluate HT-6184 in Healthy Subjects Normal Healthy Subjects | Phase 1 | 2022-06-15 |